"HIV-Associated Lipodystrophy Syndrome - Pipeline Review, H2 2012" Published
Global Markets Direct's, 'HIV-Associated Lipodystrophy Syndrome - Pipeline Review, H2 2012', provides an overview of the HIV-Associated Lipodystrophy Syndrome therapeutic pipeline. This report provides information on the therapeutic development for HIV-Associated Lipodystrophy Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for HIV-Associated Lipodystrophy Syndrome. 'HIV-Associated Lipodystrophy Syndrome - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases,...
View full press release